US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
US5391481A
(en)
|
1990-08-31 |
1995-02-21 |
The Trustees Of Columbia University |
Antibody which is directed against and inhibits collagen binding to a VLA-1 epitope and uses thereof
|
GB9022040D0
(en)
|
1990-10-10 |
1990-11-21 |
Biopharm Ltd |
Platelet adhesion inhibitor
|
US5851794A
(en)
|
1990-10-22 |
1998-12-22 |
Alfa Laval Ab |
Collagen binding protein as well as its preparation
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
AU3972793A
(en)
|
1992-04-10 |
1993-11-18 |
General Hospital Corporation, The |
Cartilage matrix protein and methods for use
|
US5491130A
(en)
|
1992-11-10 |
1996-02-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Peptide inhibitors of fibronectin and related collagen-binding proteins
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
CA2255669A1
(en)
|
1996-05-16 |
1997-11-20 |
The Texas A & M University System |
Collagen binding protein compositions and methods of use
|
US7951917B1
(en)
|
1997-05-02 |
2011-05-31 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
EP1489100B1
(en)
|
1997-12-08 |
2016-06-15 |
Merck Patent GmbH |
Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
US6387663B1
(en)
|
1998-07-31 |
2002-05-14 |
University Of Southern California |
Targeting pharmaceutical agents to injured tissues
|
WO2000021989A1
(en)
|
1998-10-09 |
2000-04-20 |
Medimmune, Inc. |
Decorin binding proteins dbp a and b and genes encoding them
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
WO2000054731A2
(en)
|
1999-03-15 |
2000-09-21 |
The General Hospital Corporation |
Syndesmos and uses thereof
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6908994B1
(en)
|
1999-05-10 |
2005-06-21 |
The Texas A&M University System |
Collagen-binding proteins from enterococcal bacteria
|
WO2000077041A2
(en)
|
1999-06-16 |
2000-12-21 |
The Texas A & M University System |
Peptides from decorin binding protein and their uses
|
AU5622800A
(en)
|
1999-06-18 |
2001-01-09 |
Med Immune, Inc. |
Combined decorin binding protein and outer surface protein compositions and methods of use
|
WO2001043763A1
(en)
|
1999-12-15 |
2001-06-21 |
Research Development Foundation |
Betaglycan as an inhibin receptor and uses thereof
|
US6777547B1
(en)
|
2000-01-31 |
2004-08-17 |
Andreas Podbielski |
Collagen-binding proteins from streptococcus pyogenes
|
US6517838B1
(en)
|
2000-06-16 |
2003-02-11 |
The Texas A&M University System |
Decorin binding protein essential peptides and methods of use
|
WO2002024223A2
(en)
|
2000-09-21 |
2002-03-28 |
The Brigham And Women's Hospital, Inc. |
Prevention and treatment of streptococcal and staphylococcal infection
|
EP2208784B1
(en)
|
2001-06-22 |
2013-01-02 |
Chugai Seiyaku Kabushiki Kaisha |
Cell proliferation inhibitors containing anti-glypican 3 antibody
|
US8192744B2
(en)
|
2002-08-26 |
2012-06-05 |
Ibcc Holding As |
Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation
|
US7488792B2
(en)
|
2002-08-28 |
2009-02-10 |
Burnham Institute For Medical Research |
Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
|
GB0406415D0
(en)
|
2004-03-22 |
2004-04-21 |
Inst Of Cancer Res The |
Materials and methods for treatment of cancer
|
US20070259380A1
(en)
|
2004-05-20 |
2007-11-08 |
Kyoichi Sumida |
Method for Measuring Hyaluronic Acid Using Hyaluronic Acid Binding Protein
|
JP2008502890A
(ja)
|
2004-06-18 |
2008-01-31 |
エフ.ホフマン−ラ ロシュ アーゲー |
結腸直腸癌のマーカーとしてのcbp2の使用
|
JP4011100B2
(ja)
|
2004-07-09 |
2007-11-21 |
中外製薬株式会社 |
抗グリピカン3抗体
|
US7820401B2
(en)
|
2004-08-23 |
2010-10-26 |
Albert Einstein College Of Medicine Of Yeshiva University |
Collagen VI and cancer
|
US20090142345A1
(en)
|
2005-03-15 |
2009-06-04 |
Takeda Pharmaceutical Company Limited |
Prophylactic/therapeutic agent for cancer
|
CA2610791C
(en)
|
2005-06-08 |
2015-12-01 |
Cangene Corporation |
Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
|
AU2006265108C1
(en)
|
2005-07-01 |
2013-01-17 |
E. R. Squibb & Sons, L.L.C. |
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
|
WO2007110205A2
(en)
|
2006-03-24 |
2007-10-04 |
Merck Patent Gmbh |
Engineered heterodimeric protein domains
|
EP1864996A1
(en)
|
2006-06-06 |
2007-12-12 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker.
|
HU0600578D0
(en)
|
2006-07-13 |
2006-09-28 |
Szilak Labor Bioinformatikai E |
Nuclear protein transport
|
EP2058659A4
(en)
|
2006-08-08 |
2009-10-21 |
Seikagaku Kogyo Co Ltd |
PROCESS FOR DETERMINING THE MOLECULAR WEIGHT OF HYALURONIC ACID
|
US8465732B2
(en)
|
2007-01-19 |
2013-06-18 |
Cornell Research Foundation, Inc. |
Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof
|
US8680247B2
(en)
|
2007-07-17 |
2014-03-25 |
Medarex, L.L.C. |
Monoclonal antibodies against glypican-3
|
EP2235064B1
(en)
|
2008-01-07 |
2015-11-25 |
Amgen Inc. |
Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
|
TW200949248A
(en)
|
2008-03-17 |
2009-12-01 |
Univ Miyazaki |
Method for detection of liver cancer cell using anti-glypican-3 antibody
|
US20090297479A1
(en)
|
2008-03-28 |
2009-12-03 |
Kiyoshi Ariizumi |
Dc-hil conjugates for treatment of t-cell disorders
|
PT2247304T
(pt)
|
2008-04-02 |
2016-08-29 |
Macrogenics Inc |
Anticorpos especificos de her2/neu e métodos de utilização dos mesmos
|
ES2399584T3
(es)
|
2008-04-15 |
2013-04-02 |
Wako Pure Chemical Industries, Ltd. |
Nueva proteína capaz de unirse al ácido hialurónico y procedimiento para medir el ácido hialurónico usando la misma
|
AU2009293007B2
(en)
|
2008-09-19 |
2015-10-08 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma
|
GB0818273D0
(en)
|
2008-10-06 |
2008-11-12 |
Cambridge Entpr Ltd |
Modulation of cellular activity and differentiation
|
KR101105428B1
(ko)
|
2009-02-12 |
2012-01-17 |
경북대학교 산학협력단 |
글리피칸-3 단백질과 특이적으로 결합하는 펩타이드
|
MX2011010166A
(es)
|
2009-04-07 |
2011-10-11 |
Roche Glycart Ag |
Anticuerpos biespecificos anti-erbb-3/anti-c-met.
|
WO2010129547A1
(en)
|
2009-05-04 |
2010-11-11 |
Purdue Research Foundation |
Collagen-binding synthetic peptidoglycans for wound healing
|
AU2010285071A1
(en)
|
2009-08-17 |
2012-02-02 |
Roche Glycart Ag |
Targeted immunoconjugates
|
WO2011028952A1
(en)
|
2009-09-02 |
2011-03-10 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
CN110066339A
(zh)
*
|
2010-04-20 |
2019-07-30 |
根马布股份公司 |
含异二聚体抗体fc的蛋白及其制备方法
|
MX346731B
(es)
|
2010-04-23 |
2017-03-30 |
Genentech Inc * |
Producción de proteínas heteromultiméricas.
|
RU2013110875A
(ru)
|
2010-08-24 |
2014-09-27 |
Ф.Хоффманн-Ля Рош Аг |
БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА, СОДЕРЖАЩИЕ СТАБИЛИЗИРОВАННЫЙ ДИСУЛЬФИДОМ ФРАГМЕНТ Fv
|
WO2012032080A1
(en)
|
2010-09-07 |
2012-03-15 |
F-Star Biotechnologische Forschungs- Und Entwicklungsges.M.B.H |
Stabilised human fc
|
US8906649B2
(en)
|
2010-09-27 |
2014-12-09 |
Janssen Biotech, Inc. |
Antibodies binding human collagen II
|
ES2758994T3
(es)
|
2010-11-05 |
2020-05-07 |
Zymeworks Inc |
Diseño anticuerpo heterodimérico estable con mutaciones en el dominio Fc
|
WO2012065978A1
(en)
|
2010-11-15 |
2012-05-24 |
Pieris Ag |
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
|
PT2647707T
(pt)
*
|
2010-11-30 |
2018-11-15 |
Chugai Pharmaceutical Co Ltd |
Agente terapêutico indutor de toxicidade
|
US10689447B2
(en)
|
2011-02-04 |
2020-06-23 |
Genentech, Inc. |
Fc variants and methods for their production
|
AU2012215573B2
(en)
*
|
2011-02-10 |
2015-11-26 |
Roche Glycart Ag |
Mutant interleukin-2 polypeptides
|
KR101614195B1
(ko)
|
2011-03-29 |
2016-04-20 |
로슈 글리카트 아게 |
항체 Fc 변이체
|
CN105968209B
(zh)
|
2011-04-19 |
2021-08-03 |
美国政府(由卫生和人类服务部的部长所代表) |
对磷脂酰肌醇蛋白聚糖3特异的人单克隆抗体及其用途
|
EA201892619A1
(ru)
|
2011-04-29 |
2019-04-30 |
Роше Гликарт Аг |
Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2
|
MX349693B
(es)
|
2011-05-24 |
2017-08-09 |
Symic Ip Llc |
Peptidoglicanos sinteticos de union a acido hialuronico, su preparacion y metodos de uso.
|
DK3351261T3
(da)
*
|
2011-10-11 |
2021-09-13 |
Univ Zuerich |
Kombinationslægemiddel omfattende IL-12 og et middel til blokering af T-celle-inhibitoriske molekyler i behandlingen af tumorer
|
WO2013070468A1
(en)
|
2011-11-08 |
2013-05-16 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
EP2804586A4
(en)
|
2012-01-19 |
2016-03-16 |
Univ Johns Hopkins |
BIOMATERIALS COMPRISING HYALURONIC ACID-BINDING PEPTIDES AND BIFUNCTIONAL BIOPOLYMER MOLECULES FOR HYALURONIC ACID RETENTION AND TISSUE ENGINEERING APPLICATIONS
|
JP6272299B2
(ja)
|
2012-04-20 |
2018-01-31 |
メルス ナムローゼ フェンノートシャップ |
Ig様分子を生産する方法、Ig様分子の混合物、組み換え宿主細胞、医薬組成物、宿主細胞を作成する方法、および培養物
|
WO2013163766A1
(en)
|
2012-05-04 |
2013-11-07 |
Cangene Corporation |
ANTIMICROBIAL COMPOSITIONS COMPRISING A HYALURONIC ACID BINDING PEPTIDE AND A β-LACTAM ANTIBIOTIC
|
US9522940B2
(en)
|
2012-05-23 |
2016-12-20 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3
|
WO2013181543A1
(en)
|
2012-06-01 |
2013-12-05 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
EP2880169B1
(en)
|
2012-08-02 |
2017-05-17 |
F. Hoffmann-La Roche AG |
Method for producing monomeric and multimeric molecules and uses thereof
|
EP2880170B1
(en)
|
2012-08-02 |
2016-08-24 |
F. Hoffmann-La Roche AG |
METHOD FOR PRODUCING SOLUBLE FcR AS Fc-FUSION WITH INERT IMMUNOGLOBULIN Fc-REGION AND USES THEREOF
|
PL3434695T3
(pl)
|
2012-08-07 |
2021-05-17 |
Roche Glycart Ag |
Ulepszona immunoterapia
|
US9951145B2
(en)
|
2012-11-27 |
2018-04-24 |
Ajou University Industry—Academic Cooperation Foundation |
CH3 domain variant pair inducing formation of heterodimer of heavy chain constant region of antibody at high efficiency, method for preparing same, and use thereof
|
WO2014145016A2
(en)
*
|
2013-03-15 |
2014-09-18 |
Genentech, Inc. |
Il-22 polypeptides and il-22 fc fusion proteins and methods of use
|
WO2014150973A1
(en)
|
2013-03-15 |
2014-09-25 |
Eli Lilly And Company |
Methods for producing fabs and bi-specific antibodies
|
US20140302037A1
(en)
*
|
2013-03-15 |
2014-10-09 |
Amgen Inc. |
BISPECIFIC-Fc MOLECULES
|
EP2970486B1
(en)
|
2013-03-15 |
2018-05-16 |
Xencor, Inc. |
Modulation of t cells with bispecific antibodies and fc fusions
|
EP3878866A1
(en)
|
2013-04-29 |
2021-09-15 |
F. Hoffmann-La Roche AG |
Fc-receptor binding modified asymmetric antibodies and methods of use
|
WO2014194100A1
(en)
|
2013-05-29 |
2014-12-04 |
The Regents Of The University Of California |
Anti-cspg4 fusions with interferon for the treatment of malignancy
|
AR096891A1
(es)
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo
|
UA117289C2
(uk)
|
2014-04-02 |
2018-07-10 |
Ф. Хоффманн-Ля Рош Аг |
Мультиспецифічне антитіло
|
US20160032007A1
(en)
|
2014-04-28 |
2016-02-04 |
Duke University |
Human Antibody Fragments Against Chondroitin Sulfate Proteoglycan 4 (CSPG4)
|
CN106471117A
(zh)
|
2014-05-06 |
2017-03-01 |
豪夫迈·罗氏有限公司 |
使用哺乳动物细胞产生异多聚体蛋白
|
US10519234B2
(en)
|
2014-06-27 |
2019-12-31 |
Innate Pharma |
NKp46 binding proteins
|
US10166304B2
(en)
|
2014-07-11 |
2019-01-01 |
Regents Of The University Of Minnesota |
Antibody fragments for detecting cancer and methods of use
|
MA40764A
(fr)
|
2014-09-26 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Agent thérapeutique induisant une cytotoxicité
|
AR102522A1
(es)
|
2014-11-06 |
2017-03-08 |
Hoffmann La Roche |
Variantes de región fc con propiedades modificadas de unión a fcrn y proteína a
|
RU2714116C2
(ru)
|
2014-11-06 |
2020-02-11 |
Ф. Хоффманн-Ля Рош Аг |
ВАРИАНТЫ Fc-ОБЛАСТИ С МОДИФИЦИРОВАННЫМ СВЯЗЫВАНИЕМ FcRn И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
JP6779873B2
(ja)
|
2014-11-12 |
2020-11-04 |
メモリアル スローン ケタリング キャンサー センター |
抗コンドロイチン硫酸プロテオグリカン4抗体およびその使用
|
JP6920207B2
(ja)
|
2015-03-20 |
2021-08-18 |
オルブセン セラピューティクス リミテッド |
シンデカン−2のモジュレーターとその使用
|
US10881711B2
(en)
|
2015-04-06 |
2021-01-05 |
The General Hospital Corporation |
Anti-CSPG4 reagents and methods of treating cancer
|
CN113881694A
(zh)
|
2015-06-24 |
2022-01-04 |
学校法人庆应义塾 |
抗磷脂酰肌醇蛋白聚糖-1-免疫抗原受体
|
RU2020143675A
(ru)
*
|
2015-08-07 |
2021-05-26 |
ЭйЭлЭкс Онколоджи Инк. |
Конструкции, имеющие sirp-альфа домен или его вариант
|
CA2998584A1
(en)
|
2015-09-14 |
2017-03-23 |
Regents Of The University Of Minnesota |
Nk cells exhibiting an adaptive phenotype and methods for preparing and for using
|
CN108884147B
(zh)
|
2015-09-23 |
2024-02-27 |
百时美施贵宝公司 |
结合磷脂酰肌醇蛋白聚糖3的基于纤连蛋白的支架分子
|
SG11201802794PA
(en)
|
2015-10-06 |
2018-05-30 |
Univ Minnesota |
Therapeutic compounds and methods
|
KR101851380B1
(ko)
|
2015-10-12 |
2018-04-23 |
아주대학교산학협력단 |
효모접합을 이용한 항체 ch3 도메인 이종이중체 돌연변이쌍 제조 방법 및 이에 의하여 제조된 ch3 돌연변이체 쌍
|
KR101796688B1
(ko)
|
2015-10-29 |
2017-12-01 |
재단법인 목암생명과학연구소 |
신규 항-글리피칸 3 항체 및 이를 포함하는 약학적 조성물
|
CN109415435B
(zh)
|
2016-07-04 |
2024-01-16 |
豪夫迈·罗氏有限公司 |
新型抗体形式
|
EP3494135A1
(en)
|
2016-08-02 |
2019-06-12 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Monoclonal antibodies targeting glypican-2 (gpc2) and use thereof
|
WO2018030806A1
(ko)
*
|
2016-08-10 |
2018-02-15 |
아주대학교산학협력단 |
항체 중쇄불변부위 이종이중체에 융합된 사이토카인 및 이를 포함하는 약제학적 조성물
|
CN110267977A
(zh)
|
2016-08-10 |
2019-09-20 |
亚洲大学校产学协力团 |
细胞因子免疫球蛋白Fc融合异二聚体和包含其的药物组合物
|
KR102649972B1
(ko)
*
|
2016-10-14 |
2024-03-22 |
젠코어 인코포레이티드 |
IL15/IL15Rα 이종이량체 Fc-융합 단백질
|
CN110944661A
(zh)
|
2017-02-20 |
2020-03-31 |
蜻蜓疗法股份有限公司 |
结合her2、nkg2d和cd16的蛋白质
|
CN110831634A
(zh)
|
2017-03-08 |
2020-02-21 |
密歇根大学董事会 |
磷脂酰肌醇蛋白聚糖-3肽试剂和方法
|
MA49270A
(fr)
|
2017-03-27 |
2020-02-05 |
Hoffmann La Roche |
Récepteurs de liaison à l'antigène améliorés
|
CN110691793A
(zh)
|
2017-04-26 |
2020-01-14 |
田边三菱制药株式会社 |
黏结蛋白聚糖-1(cd138)结合剂及其用
|
EP3617231A4
(en)
|
2017-04-28 |
2021-04-07 |
National University Corporation Kochi University |
ANTI-GPC-1 ANTIBODY
|
JP2019014449A
(ja)
|
2017-07-10 |
2019-01-31 |
トヨタ自動車株式会社 |
車両用動力伝達装置
|
EP3679071A4
(en)
|
2017-09-07 |
2021-06-09 |
Dragonfly Therapeutics, Inc. |
PROTEINS THAT BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
|
CN111132997A
(zh)
*
|
2017-09-21 |
2020-05-08 |
默克专利有限公司 |
包含fgf-18部分的融合蛋白
|
WO2019057122A1
(en)
*
|
2017-09-22 |
2019-03-28 |
Wuxi Biologics (Shanghai) Co., Ltd. |
NEW BISPECIFIC POLYPEPTIDE COMPLEXES
|
CA3078157A1
(en)
|
2017-10-20 |
2019-04-25 |
F.Hoffmann-La Roche Ag |
Method for generating multispecific antibodies from monospecific antibodies
|
AU2019218125A1
(en)
|
2018-02-08 |
2020-08-20 |
Dragonfly Therapeutics, Inc. |
Combination therapy of cancer involving multi-specific binding proteins that activate natural killer cells
|
DE102018208278A1
(de)
|
2018-05-25 |
2019-11-28 |
Robert Bosch Gmbh |
Betriebsassistenzverfahren, Steuereinheit, Betriebsassistenzsystem und Arbeitsvorrichtung
|
KR20210042326A
(ko)
*
|
2018-07-11 |
2021-04-19 |
모멘타 파머슈티컬스 인코포레이티드 |
조작된 Fc-항원 결합 도메인 작제물에 관련된 조성물 및 방법
|
CA3117212A1
(en)
|
2018-10-23 |
2020-04-30 |
Dragonfly Therapeutics, Inc. |
Heterodimeric fc-fused proteins
|